Assyro AI

FDA Orange Book · active-ingredient family

Magnesium sulfate; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium phosphate

Magnesium sulfate; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium phosphate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:TIS-U-SOL · NDA 018508

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
TIS-U-SOLBAXTER HLTHCARENDA 018508ATFeb 19, 1982
TIS-U-SOL IN PLASTIC CONTAINERBAXTER HLTHCARENDA 018336ATApproved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Magnesium sulfate; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium phosphate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.